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Research 1: Droplet digital PCR assay for RHOA mutation detection in angioimmunoblastic 
T-cell lymphoma 
目    的：Angioimmunoblastic T-cell lymphoma (AITL) is a subtype of nodal peripheral 
T-cell lymphoma (PTCL). Besides, a part of peripheral T-cell lymphoma not otherwise specified 
(PTCL-NOS) which is referred to nodal PTCL with TFH phenotype share similar genetic features 
of AITL. The hotspot mutation is the G17V RHOA mutations which was observed approximately 
60% of the cases. Routine detection of the G17V RHOA mutation is troublesome as tumor contents 
are low in clinical specimen. In addition, quality of genomic DNAs derived from biopsy specimens 
are relatively poor. Therefore, my purpose was to establish a sensitive method to detect G17V 
RHOA mutation in clinical samples. 
 
対象と方法：I analyzed 67 PTCL (40 AITL and 27 PTCL-NOS) patient samples by droplet 
digital PCR (ddPCR), and compared the results with PNA-LNA clamp method and next 
generation sequencing. 
 
結    果：The G17V RHOA mutation was identified in 28 of 67 (41.8%) PTCL samples. 
ddPCR assay and PNA-LNA clamp method both detected the mutations in 32 of 67 (47.8%) 
samples. Three other RHOA mutations (p.Gly17Val, p.Gly17Leu, and p.Gly17Glu) which were 
detected by NGS, could not be detected by  ddPCR and PNA-LNA clamp method. Variant allele 
frequencies by ddPCR and those by NGS showed high concordance (p<0.001). 
 
 考    察：The ddPCR and PNA-LNA clamp method were more sensitive for detection of 
low frequency mutations than NGS, although NGS was convenient for detection of exact 
mutational types. 
 
結    論：A combination of ddPCR or PNA-LNA clamp method and NGS was required 
for appropriate diagnosis of AITL. 
 
Research 2: Analysis of control region of mitochondrial DNA in samples of diffuse large B-
cell lymphoma. 
目    的：Diffuse large B-cell lymphoma (DLBCL, incidence 37%) is the most prevalent 
entities of mature B-cell neoplasms in adulthood. Tumor-related somatic mutations of DNA in 
cancer patients is being used thoroughly to acquire genetic information. Not only genomic DNA 
but also tumor derived mutant mitochondrial DNA (mtDNA) can serve as a predictive biomarker, 
because, mitochondrial D-loop region is known as a hotspot for mutations and control region (CR) 
controls mitochondrial transcription and replication process. The purpose of this study was to 
evaluate the mutation frequency in control region of mitochondrial DNA in DLBCL patients. 
 
対象と方法：I collected tumor and paired bone marrow from DLBCL patients and detected 
somatic mutations by NGS. 
 結    果：I found somatic mutations in 2 out of 14 (14%) tumor samples in control region 
(CR) of mtDNA. I also found 4 presumably heteroplasmic mutations, among these mutations 
m.16093T>C was known site of tissue specific heteroplasmy which was found in two patients. 
 
考    察：Disease-specific somatic mutations and recurrent heteroplasmic mutations were 
present in mtDNA of DLBCL patients. 
結    論：For studying the molecular mechanism of DLBCL, mtDNA can be considered 
as potential target to detect mutations other than genomic DNA.  
 
 
